University of Muenster

Bispecific antibodies that are designed to target cancer cells and engage T-cells gained momentum at the recent American Society of Hematology (ASH) conference, prompting the question of whether these

Kite Pharma Inc. recently told investors that it's on the cusp of producing late-stage data that could enable a filing of its lead cancer immunotherapy candidate, KTE-C19, but the biotech also recen

Abbisko Therapeutics Abbisko brings in $28mm via Series A China-based Abbisko Therapeutics raised $28mm through its Series A financing to Lilly Asia Ventures, Sinopharm Capital, Jianxin Capita

In Vitro Diagnostics Acquisitions /In Vitro Diagnostics Agilent Technologies Inc. Stratagene Corp. Agilent Technologies (bioanalytical and electronic measurement instruments) is paying $10.94 in cas